Pharmacokinetics of a long-acting bromocriptine preparation (Parlodel LA) and its effect on release of prolactin and growth hormone

This publication has 21 references indexed in Scilit:

• Inhibition of Lactation by a New Long-Acting as Well as Oral Bromocriptine: Evidence for a Low Threshold of Prolactin for Lactation
  Annals of the New York Academy of Sciences, 1986
• Evidence for a Limited Growth Hormone (GH)-Releasing Hormone (GHRH)-Releasable Quantity of GH: Effects of 6-Hour Infusions of GHRH on GH Secretion in Normal Man*
  Journal of Clinical Endocrinology & Metabolism, 1985
• Growth hormone releasing factor infusion does not sustain elevated GH-levels in normal subjects
  Acta Endocrinologica, 1984
• INJECTABLE BROMOCRIPTINE TO TREAT ACUTE, OESTROGEN-INDUCED SWELLING OF INVASIVE PROLACTINOMA
  The Lancet, 1984
• Plasma growth hormone responses to constant infusions of human pancreatic growth hormone releasing factor. Intermittent secretion or response attenuation.
  Journal of Clinical Investigation, 1984
• Ectopic Growth Hormone-Releasing Factor Stimulates Growth Hormone Secretion in the Urethane-Anesthetized Rat in vivo
  Neuroendocrinology, 1983
• Characterization of ergot and non-ergot serotonin antagonists by prolactin and growth hormone profiles during wakefulness and sleep
  Brain Research, 1980
• EFFECT OF BROMOCRIPTIN ON THE ENDOCRINE SYSTEM AND FETAL DEVELOPMENT
  Clinical Endocrinology, 1977
• Effect of 2-Br-α-Ergocryptine on Pituitary Synthesis and Release of Prolactin and Growth Hormone in Rats
  Hormone Research, 1974
• A Radioimmunoassay for Human Prolactin
  Proceedings of the National Academy of Sciences, 1971